Butler Hall Capital LLC has issued an open letter to VNDA’s board of directors urging the company to run a full sales process to maximize shareholder value
April 19 2024 - 12:04PM
A fund managed by Butler Hall Capital LLC, with current ownership
350,000 shares of Vanda Pharmaceuticals Inc. (“Vanda” or the
“Company”), has issued an open letter to the Company’s board of
directors (the “Board”) regarding the potential bid for Vanda
submitted by Future Pak, LLC (“Future Pak”).
A full copy of the letter is attached below and is available
at: http://ml.globenewswire.com/Resource/Download/9ee5bd01-bdbc-43f7-af2d-e4c34004b336
Contacts:
Michael Rybak
424-644-6008
Brad Lundy
424-644-6009